Alpine Immune Sciences, Inc.

NasdaqGM:ALPN Stok Raporu

Piyasa değeri: US$4.5b

Alpine Immune Sciences Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Alpine Immune Sciences'in kazancının yıllık 9.9% oranında azalması, yıllık gelirinin ise yıllık 34.2% oranında artması beklenmektedir. EPS'nin düşmesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde -78.4% olacağı tahmin edilmektedir.

Anahtar bilgiler

-9.9%

Kazanç büyüme oranı

-11.0%

EPS büyüme oranı

Biotechs kazanç büyümesi27.3%
Gelir büyüme oranı34.2%
Gelecekteki özkaynak getirisi-78.4%
Analist kapsamı

Good

Son güncelleme17 May 2024

Gelecekteki son büyüme güncellemeleri

Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Mar 21
Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement

Apr 11

Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Mar 21
Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Mar 20
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug

Mar 07

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Feb 07
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

Dec 19
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Sep 23
We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

May 11
Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Dec 12
Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Alpine Immune Sciences drops 13% after hours on $100M stock offering

Sep 20

Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Aug 09
Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Alpine: Rest Before Rallying Again

Apr 25

Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Apr 12
Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Sep 18
Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

Aug 18
Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

Kazanç ve Gelir Büyüme Tahminleri

NasdaqGM:ALPN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202610-149-173-1507
12/31/202520-110-140-1138
12/31/202418-97-96-917
3/31/202457-37-81-81N/A
12/31/202359-32-79-79N/A
9/30/202331-57-77-77N/A
6/30/202329-59-78-77N/A
3/31/202326-64-76-75N/A
12/31/202230-58-44-44N/A
9/30/202232-54-42-42N/A
6/30/202232-5445N/A
3/31/202234-4766N/A
12/31/202123-50-15-15N/A
9/30/202125-42-10-10N/A
6/30/202118-34-46-45N/A
3/31/202111-332324N/A
12/31/20209-282930N/A
9/30/20205-283334N/A
6/30/20203-332829N/A
3/31/20203-35-35-34N/A
12/31/20192-42-36-35N/A
9/30/20191-47-39-39N/A
6/30/20191-48-36-36N/A
3/31/20190-44-35-35N/A
12/31/20181-36-29-28N/A
9/30/20181-30-25-25N/A
6/30/20181-15-23-22N/A
3/31/20181-11-19-19N/A
12/31/20172-8N/A-17N/A
9/30/20172-5N/A-13N/A
6/30/20173-7N/A-9N/A
3/31/20173-3N/A-6N/A
12/31/20163-1N/A-4N/A
12/31/201500N/A5N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: ALPN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: ALPN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: ALPN önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: ALPN şirketinin gelirinin (yıllık 34.2% ) US pazarından (yıllık 8.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: ALPN şirketinin gelirinin (yıllık 34.2% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: ALPN 3 yıl içinde kârsız olması bekleniyor.


Büyüyen şirketleri keşfedin